Insider · CIK 0001528391

Ross Julian T

Reports to the SEC for 1 company · FRISCO, TX

sec.gov

Transactions

Companies

Filings

CIK

0001528391

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-12-31	OxySure Therapeutics, Inc.A Award	Director, CEO, 10% Owner	AAward	+500K sh	$0.20	+$100K	672,324
2015-12-31	OxySure Therapeutics, Inc.Options (right to buy)A Award	Director, CEO, 10% Owner	AAward	+1M sh	$0.20	+$200K	2,417,488
2015-12-31	OxySure Therapeutics, Inc.A Award	Director, CEO, 10% Owner	AAward	+500K sh	$0.20	+$100K	672,324
2015-12-31	OxySure Therapeutics, Inc.Options (right to buy)A Award	Director, CEO, 10% Owner	AAward	+1M sh	$0.20	+$200K	2,417,488
2015-08-04	OxySure Therapeutics, Inc.P Purchase	Director, CEO, 10% Owner	PPurchase	+1,000 sh	$0.41	+$410	172,324
2015-07-29	OxySure Therapeutics, Inc.P Purchase	Director, CEO, 10% Owner	PPurchase	+3,500 sh	$0.45	+$1,578.85	171,324
2015-07-23	OxySure Therapeutics, Inc.P Purchase	Director, CEO, 10% Owner	PPurchase	+10.2K sh	$0.50	+$5,054.1	167,824
2015-06-04	OxySure Therapeutics, Inc.P Purchase	Director, CEO, 10% Owner	PPurchase	+4,500 sh	$0.66	+$2,980.35	157,624
2015-05-28	OxySure Therapeutics, Inc.P Purchase	Director, CEO, 10% Owner	PPurchase	+2,000 sh	$0.69	+$1,385	153,124
2015-05-27	OxySure Therapeutics, Inc.P Purchase	Director, CEO, 10% Owner	PPurchase	+5,100 sh	$0.68	+$3,481.26	151,124
2015-05-26	OxySure Therapeutics, Inc.P Purchase	Director, CEO, 10% Owner	PPurchase	+2,800 sh	$0.67	+$1,874.6	146,024
2015-05-26	OxySure Therapeutics, Inc.P Purchase	Director, CEO, 10% Owner	PPurchase	+15K sh	$0.67	+$10K	14,040,761
2015-02-16	OxySure Therapeutics, Inc.G Gift	Director, CEO, 10% Owner	GGift	−15K sh	—	—	14,025,761
2015-02-14	OxySure Therapeutics, Inc.J Other	Director, CEO, 10% Owner	JOther	−60K sh	$0.10	−$6,000	143,224
2015-02-10	OxySure Therapeutics, Inc.J Other	Director, CEO, 10% Owner	JOther	−190K sh	$0.53	−$99.9K	203,224
2015-02-06	OxySure Therapeutics, Inc.L Small Acquisition	Director, CEO, 10% Owner	LSmall Acquisition	+9,400 sh	$0.69	+$6,514.2	393,224
2014-12-31	OxySure Therapeutics, Inc.L Small Acquisition	Director, CEO, 10% Owner	LSmall Acquisition	+3,950 sh	$0.85	+$3,353.55	383,824
2014-07-02	OxySure Therapeutics, Inc.Options (right to buy)A Award	Director, CEO, 10% Owner	AAward	+150K sh	—	—	150,000
2014-02-12	OxySure Therapeutics, Inc.L Small Acquisition	Director, CEO, 10% Owner	LSmall Acquisition	+6,300 sh	$0.65	+$4,100.04	379,874
2014-02-12	OxySure Therapeutics, Inc.G Gift	Director, CEO, 10% Owner	GGift	−100K sh	—	—	14,025,761
2013-12-13	OxySure Therapeutics, Inc.L Small Acquisition	Director, CEO, 10% Owner	LSmall Acquisition	+2,100 sh	$0.77	+$1,623.09	373,574
2013-06-05	OxySure Therapeutics, Inc.Options (right to buy)A Award	Director, CEO, 10% Owner	AAward	+120K sh	—	—	1,417,488
2013-06-05	OxySure Therapeutics, Inc.Options (right to buy)A Award	Director, CEO, 10% Owner	AAward	+120K sh	—	—	1,297,488
2013-02-11	OxySure Therapeutics, Inc.J Other	Director, CEO, 10% Owner	JOther	+15K sh	$0.98	+$14.7K	16,820,285
2013-02-11	OxySure Therapeutics, Inc.S Sale	Director, CEO, 10% Owner	SSale	−50K sh	$0.63	−$31.5K	16,820,285
2012-12-31	OxySure Therapeutics, Inc.C Conversion	Director, CEO, 10% Owner	CConversion	+846K sh	$1.50	+$1.27M	16,870,285
2012-12-31	OxySure Therapeutics, Inc.Convertible SecuritiesC Conversion	Director, CEO, 10% Owner	CConversion	−846K sh	$1.50	−$1.27M	16,870,285
2012-04-02	OxySure Therapeutics, Inc.X Exercise of In-Money	Director, CEO, 10% Owner	XExercise of In-Money	+588K sh	$0.01	+$5,881.72	16,762,618
2012-04-02	OxySure Therapeutics, Inc.M Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	+356K sh	$0.25	+$89.1K	16,762,618
2012-04-02	OxySure Therapeutics, Inc.WarrantsX Exercise of In-Money	Director, CEO, 10% Owner	XExercise of In-Money	−588K sh	$0.01	−$5,881.72	16,762,618
2012-04-02	OxySure Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Director, CEO, 10% Owner	MExercise/Conversion	−356K sh	$0.25	−$89.1K	16,762,618
2012-03-23	OxySure Therapeutics, Inc.G Gift	Director, CEO, 10% Owner	GGift	−108K sh	—	—	16,762,618
2011-12-31	OxySure Therapeutics, Inc.WarrantsA Award	Director, CEO, 10% Owner	AAward	+21K sh	—	—	21,000
2011-10-13	OxySure Therapeutics, Inc.C Conversion	Director, CEO, 10% Owner	CConversion	+336K sh	—	—	16,642,580
2011-10-13	OxySure Therapeutics, Inc.Convertible SecuritiesC Conversion	Director, CEO, 10% Owner	CConversion	+336K sh	$1.00	+$336K	16,642,580
2011-09-30	OxySure Therapeutics, Inc.WarrantsA Award	Director, CEO, 10% Owner	AAward	+35K sh	—	—	35,006
2011-01-15	OxySure Therapeutics, Inc.Options (Right to buy)A Award	Director, CEO, 10% Owner	AAward	+30K sh	—	—	165,000

Recent filings

Accepted (ET)
Mar 35/A
OxySure Therapeutics, Inc.0001547522-16-000227
SEC(opens sec.gov)
Feb 165
OxySure Therapeutics, Inc.0001547522-16-000215
SEC(opens sec.gov)
Aug 144
OxySure Systems Inc0001547522-15-000142
SEC(opens sec.gov)
Jul 294
OxySure Systems Inc0001547522-15-000130
SEC(opens sec.gov)
Jul 244
OxySure Systems Inc0001547522-15-000128
SEC(opens sec.gov)
Jun 44
OxySure Systems Inc0001547522-15-000111
SEC(opens sec.gov)
May 294
OxySure Systems Inc0001547522-15-000109
SEC(opens sec.gov)
May 274
OxySure Systems Inc0001547522-15-000107
SEC(opens sec.gov)
May 264
OxySure Systems Inc0001547522-15-000105
SEC(opens sec.gov)
Feb 175
OxySure Systems Inc0001213900-15-001193
SEC(opens sec.gov)
Feb 145
OxySure Systems Inc0001213900-14-000882
SEC(opens sec.gov)

Companies

OxySure Therapeutics, Inc.Director, CEO, 10% Owner

Address

10880 JOHN W. ELLIOT DRIVE SUITE 600

FRISCO, TX, 75034